版本:
中国

BRIEF-Knight therapeutics Q1 EPS $0.04

May 11 Knight Therapeutics Inc :

* Knight Therapeutics Inc qtrly revenues of $1.8 million, an increase of $682,000 over same period last year

* Knight reports first quarter 2017 results

* Qtrly diluted earnings per share $0.04

* Received full repayment of balance of secured loans to Apicore Inc. and Pro Bono Bio Plc in the quarter Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐